The highly anticipated new obesity pill shows the potential for greater and faster weight loss than Wegovy. There is a new ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Novo Nordisk said on Wednesday its highly anticipated experimental weight-loss pill amycretin was safe and tolerable for ...

In a late-stage clinical trial, a drug similar to Ozempic was shown to reduce body mass index in kids ages 6 to 11 with ...

Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...

Eli Lilly and Novo Nordisk have been top stocks for investors who are bullish on the weight loss market. However, fellow ...

Nonprofit group the Obesity Action Coalition (OAC) is running a new challenge as part of its “Your Weight Matters” ...

A pair of late-stage trials found that Eli Lilly’s experimental once-weekly insulin can lower blood sugar as effectively as ...

Eli Lilly's new insulin data —Sanofi x Regeneron autoimmune drugs —Gilead's new AI partnership Get the full rundown here: ...

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists ...

In a report released today, Peter Verdult from Citi initiated coverage with a Buy rating on Eli Lilly & Co (LLY – Research Report) ...